McKesson Analyst Ratings
Argus Adjusts Price Target on McKesson to $670 From $570
Deutsche Bank Adjusts Price Target on McKesson to $631 From $545
Maxon Corporation: Baird raised the target price from $671 to $679
JPMorgan Adjusts McKesson Price Target to $656 From $589
Buy Rating Reaffirmed for McKesson on Strong Growth and Robust Financials
McKesson: Hold Rating Amidst Strong Outlook and Valuation Concerns
Deutsche Bank: Maintaining the McKesson (MCK.US) rating, adjusted from buy to buy rating, and adjusted the target price from $547.00 to $545.00.
McKesson Analyst Ratings
Wells Fargo Adjusts Price Target on McKesson to $551 From $502
Barclays Maintains Overweight on McKesson, Raises Price Target to $596
TD Cowen Maintains Buy on McKesson, Raises Price Target to $652
McKesson Analyst Ratings
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $600
UBS Adjusts Price Target on McKesson to $630 From $620, Maintains Buy Rating
UBS Maintains Buy on McKesson, Raises Price Target to $630
McKesson Analyst Ratings
Baird Maintains Outperform on McKesson, Raises Price Target to $671
Analysts' Opinions Are Mixed on These Healthcare Stocks: Masimo (MASI), Halozyme (HALO) and McKesson (MCK)
Barclays Sticks to Their Buy Rating for McKesson (MCK)